COGNIGENICS

cognigenics-logo

Cognigenics transforms mental health in the genetic age through cognitive neuroengineering. The company’s business is cognitive neuroengineering, which is the genetic engineering of desirable cognitive traits, such as mindfulness, relaxation, and mental acuity. These cognitive assets can enhance human performance in normal individuals or offset cognitive deficits in people suffering from mental health issues such as stress, anxiety, and depression (which are the initial applications).

#SimilarOrganizations #Website #More

COGNIGENICS

Social Links:

Industry:
Genetics Neuroscience Psychology

Founded:
2019-06-26

Website Url:
http://www.cognigenics.io

Total Employee:
1+

Status:
Active

Contact:
772-324-8800

Email Addresses:
[email protected]

Total Funding:
1.59 M USD

Technology used in webpage:
SPF Apache Euro Sectigo SSL Sectigo Domain SSL Bizland


Similar Organizations

gratanium-logo

Gratanium

Advertising Agency

Official Site Inspections

http://www.cognigenics.io

  • Host name: 138.179.233.35.bc.googleusercontent.com
  • IP address: 35.233.179.138
  • Location: Mountain View United States
  • Latitude: 37.4043
  • Longitude: -122.0748
  • Metro Code: 807
  • Timezone: America/Los_Angeles
  • Postal: 94043

Loading ...

More informations about "Cognigenics" on Search Engine

Cognigenics | LinkedIn

1. Cognigenics | 407 followers on LinkedIn. Shaping the Future of Genetic Medicines for Mental Health and Neurocognitive Disorders | Cognigenics develops innovative RNA-based gene therapies ...See details»

Cognigenics - Crunchbase Company Profile & Funding

Details. Cognigenics transforms mental health in the genetic age through cognitive neuroengineering. The company’s business is cognitive neuroengineering, which is the …See details»

David Pyrce Appointed as New CEO of Cognigenics, Inc.

Jan 16, 2024 Cognigenics is advancing mental health treatment for cognitive impairment and neurodegenerative disorders through novel, proprietary genetic neuroengineering …See details»

Cognigenics to Present at Biotech Showcaseâ„¢ 2024

Jan 8, 2024 Cognigenics, Inc., is pioneering next-generation therapeutic approaches to treating mental health, neuropsychiatric and neurodegenerative disorders.See details»

David Pyrce Appointed as New CEO of Cognigenics, Inc.

Jan 16, 2024 Cognigenics, Inc., a leader in innovative RNA-based gene therapies targeting memory loss, cognitive decline, anxiety associated with mild cognitive …See details»

David Pyrce Appointed as New CEO of Cognigenics, Inc. - Yahoo …

STUART, Fla., January 16, 2024 -- ( BUSINESS WIRE )--Cognigenics, Inc., a leader in innovative RNA-based gene therapies targeting memory loss, cognitive decline, anxiety …See details»

Cognigenics to Present at Biotech Showcase™ 2024 - Yahoo …

Business Wire. Mon, Jan 8, 2024 2 min read. JUPITER, Fla., January 08, 2024 -- ( BUSINESS WIRE )--Cognigenics, Inc., is pioneering next-generation therapeutic …See details»

Cognigenics' Intranasal CRISPR Delivery Bypasses Blood-Brain …

Jun 22, 2023 Cognigenics' Intranasal CRISPR Delivery Bypasses Blood-Brain Barrier; Potential Breakthrough Therapeutic. Business Wire. June 22, 2023 · 2 min read. Study: …See details»

Company: Cognigenics

Cognigenics. Company Type: Therapeutics. Main focus: Non-viral delivery of CRISPR-based therapeutics to central nervous system. Company stage: Pre-clinical. Diseases: …See details»

Cognigenics - Funding, Financials, Valuation & Investors

Cognigenics has raised a total of. $1.6M. in funding over 1 round. This was a Seed round raised on Aug 16, 2022. Cognigenics is funded by Lionheart Ventures. Unlock for free.See details»

Cognigenics to Present at Biotech Showcaseâ„¢ 2024 | Morningstar

Jan 8, 2024 Business Wire. Cognigenics to Present at Biotech Showcaseâ„¢ 2024. Provided by Business Wire. Jan 8, 2024 10:00 AM UTC. Cognigenics to Present at …See details»

Cognigenics' Intranasal CRISPR Delivery Bypasses Blood-Brain …

Jun 22, 2023 About Cognigenics. Founded in 2019, Cognigenics works at the forefront of genetic neuroengineering through patent-pending CRISPR technology to precisely and …See details»

Cognigenics, Inc. | VentureRadar

Founded in 2019. Private Company. Develops novel treatments for various mental health issues using patent-pending cognitive neuroengineering techniques with anticipated high …See details»

Cognigenics - Contacts, Employees, Board Members, Advisors

Cognigenics. Connect to CRM. Summary Financials People Technology Signals & News Similar Companies. Highlights. Employee Profiles 1. Contacts 1. About. Cognigenics …See details»

Cognigenics - Crunchbase

Cognigenics, Innervace, Scout Bio, Spark Therapeutics, Tmunity Therapeutics, and iECURE are all involved in the biotechnology and genetic therapy sector. Innervace, …See details»

Cognigenics - Tech Stack, Apps, Patents & Trademarks

Cognigenics. Connect to CRM. Summary Financials People Technology Signals & News Similar Companies. Highlights. Active Tech Count 8. Monthly Visits 546. About. …See details»